You are currently viewing a new version of our website. To view the old version click .

4,771 Results Found

  • Case Report
  • Open Access
1 Citations
641 Views
5 Pages

Primary Immune Thrombocytopenia in a Patient with Sarcoidosis

  • Marta Dąbrowska,
  • Rafał Krenke,
  • Marta Maskey-Warzęchowska,
  • Piotr Boguradzki,
  • Anna Waszczuk-Gajda,
  • Wiesław Wiktor Jędrzejczak,
  • Paweł Caban and
  • Ryszarda Chazan

22 August 2011

Sarcoidosis is a disease characterised by a highly variable clinical course. While it may be accompanied by various immune disorders, it is rarely accompanied by disorders of the haematopoietic system. We report a case of sudden-onset primary immune...

  • Article
  • Open Access
3 Citations
4,105 Views
15 Pages

Down Syndrome in Children: A Primary Immunodeficiency with Immune Dysregulation

  • Aleksandra Szczawińska-Popłonyk,
  • Natalia Popłonyk and
  • Karina Awdi

17 October 2024

Background: The multisystemic features of Down syndrome (DS) in children are accompanied by immunodeficiency, making them susceptible to infections and immune dysregulation with autoimmune, allergic, inflammatory, and hematological complications. Thi...

  • Review
  • Open Access
22 Citations
5,114 Views
13 Pages

Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma

  • Hans-Georg Wirsching,
  • Michael Weller,
  • Stefan Balabanov and
  • Patrick Roth

20 June 2021

This review article outlines the current development of emerging treatment strategies for primary central nervous system lymphoma, a rare brain tumor with, thus far, limited therapeutic options. Small molecule targeted tyrosine kinase inhibitors, imm...

  • Review
  • Open Access
53 Citations
6,092 Views
14 Pages

22 January 2019

Immune checkpoint inhibitors (ICPis) have revolutionized cancer therapy with broad activities against a wide range of malignancies. However, in many malignancies their efficacy remains limited due to the primary resistance. Furthermore, a high percen...

  • Review
  • Open Access
8 Citations
4,807 Views
21 Pages

Antibodies against immune checkpoint inhibitors (ICIs) have revolutionized the treatment of multiple aggressive malignancies, including melanoma and non-small cell lung cancer. ICIs for the treatment of primary and metastatic brain tumors have been u...

  • Article
  • Open Access
1 Citations
4,122 Views
17 Pages

9 July 2021

Germinal centers (GCs) are transient structures in the secondary lymphoid organs, where B cells undergo affinity maturation to produce high affinity memory and plasma cells. The lifetime of GC responses is a critical factor limiting the extent of aff...

  • Review
  • Open Access
13 Citations
3,549 Views
11 Pages

Primary and Acquired Resistance against Immune Check Inhibitors in Non-Small Cell Lung Cancer

  • Qinying Sun,
  • Xiangzhen Wei,
  • Zhonglin Wang,
  • Yan Zhu,
  • Weiying Zhao and
  • Yuchao Dong

6 July 2022

Immune checkpoint inhibitors have emerged as the treatment landscape of advanced non-small cell lung cancer (NSCLC) in recent years. However, approximately 80% of NSCLC patients do not benefit from ICIs due to primary resistance (no initial response)...

  • Article
  • Open Access
5 Citations
3,129 Views
20 Pages

Can Machine Learning Assist in Diagnosis of Primary Immune Thrombocytopenia? A Feasibility Study

  • Haroon Miah,
  • Dimitrios Kollias,
  • Giacinto Luca Pedone,
  • Drew Provan and
  • Frederick Chen

Primary Immune Thrombocytopenia (ITP) is a rare autoimmune disease characterised by the immune-mediated destruction of peripheral blood platelets in patients leading to low platelet counts and bleeding. The diagnosis and effective management of ITP a...

  • Review
  • Open Access
1,374 Views
16 Pages

Gut–Liver Axis, Microbiota, Bile Acids, and Immune Response in Pathogenesis of Primary Sclerosing Cholangitis: An Overview

  • Fotios S. Fousekis,
  • Konstantinos Mpakogiannis,
  • Georgios D. Lianos,
  • Elisabetta Antonelli,
  • Gabrio Bassotti and
  • Konstantinos H. Katsanos

3 November 2025

Primary sclerosing cholangitis (PSC) is a chronic, immune-mediated cholestatic liver disease characterized by progressive bile duct inflammation and fibrosis. Its strong association with inflammatory bowel disease (IBD) highlights the possible role o...

  • Communication
  • Open Access
11 Citations
2,441 Views
13 Pages

Immune Transcriptional Response in Head Kidney Primary Cell Cultures Isolated from the Three Most Important Species in Chilean Salmonids Aquaculture

  • Daniela P. Nualart,
  • Francisco Dann,
  • Ricardo Oyarzún-Salazar,
  • Francisco J. Morera and
  • Luis Vargas-Chacoff

28 June 2023

Fish cell culture is a common in vitro tool for studies in different fields such as virology, toxicology, pathology and immunology of fish. Fish cell cultures are a promising help to study how to diagnose and control relevant viral and intracellular...

  • Review
  • Open Access
1,550 Views
12 Pages

24 July 2025

Viruses use a range of sophisticated strategies to evade detection by cytotoxic T-lymphocytes (CTLs) within host cells. Beyond elaborating dedicated viral proteins that disrupt the MHC class I antigen-presentation machinery, some viruses possess intr...

  • Feature Paper
  • Article
  • Open Access
2 Citations
4,513 Views
14 Pages

Implementation of Primary Immune Thrombocytopenia Clinical Practice Guidelines for Management of Pregnancy

  • Amanda J. Llaneza,
  • Laura A. Beebe,
  • Janis E. Campbell,
  • Marshall K. Cheney,
  • Ying Zhang and
  • Deirdra R. Terrell

29 October 2024

Background: Managing primary immune thrombocytopenia (ITP) in pregnancy is challenging. Providers must balance bleeding risk against medication toxicity. The evaluation of the implementation of pregnancy-specific ITP clinical guidelines has not been...

  • Article
  • Open Access
7 Citations
3,069 Views
16 Pages

The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity

  • Eman Mostafa Hamed,
  • Ahmed R. N. Ibrahim,
  • Mohamed Hussein Meabed,
  • Ahmed M. Khalaf,
  • Doaa Mohamed El Demerdash,
  • Marwa O. Elgendy,
  • Haitham Saeed,
  • Heba F. Salem and
  • Hoda Rabea

Immune thrombocytopenia (ITP) treatment has evolved recently. However, none of the treatments have only benefits without drawbacks. This study aimed to compare the clinical outcomes and adverse drug patterns of Eltrombopag, Romiplostim, Prednisolone...

  • Article
  • Open Access
14 Citations
2,954 Views
14 Pages

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer

  • Yiqing Huang,
  • Joseph J. Zhao,
  • Yu Yang Soon,
  • Adrian Kee,
  • Sen Hee Tay,
  • Folefac Aminkeng,
  • Yvonne Ang,
  • Alvin S. C. Wong,
  • Lavina D. Bharwani and
  • Boon Cher Goh
  • + 1 author

12 May 2023

Introduction: Primary resistance to immune checkpoint inhibitors (ICI) is observed in routine clinical practice. We sought to determine factors predictive of primary resistance to ICI monotherapy, defined by the Society for Immunotherapy of Cancer (S...

  • Article
  • Open Access
2 Citations
758 Views
11 Pages

Budget Impact Analysis for Avatrombopag in the Treatment of Chronic Primary Immune Thrombocytopenia in Adult Patients Refractory to Other Treatments

  • Andrea Aiello,
  • Elisa Elena Mariano,
  • Mariangela Prada,
  • Cristina Teruzzi,
  • Nicoletta Martone,
  • Stefano Capri,
  • Giuseppe Carli and
  • Sergio Siragusa

ABSTRACT Introduction: Primary immune thrombocytopenia is a rare autoimmune disease characterised by a decreased platelet count resulting in an increased risk of bleeding events and even life-threatening haemorrhages. Thrombopoietin receptor agonist...

  • Article
  • Open Access
5 Citations
2,930 Views
15 Pages

TCR CDR3 Sequencing as a Clue to Elucidate the Landscape of Dysimmunity in Patients with Primary Immune Thrombocytopenia

  • Lili Ji,
  • Yanxia Zhan,
  • Boting Wu,
  • Pu Chen,
  • Luya Cheng,
  • Yang Ke,
  • Xibing Zhuang,
  • Fanli Hua,
  • Lihua Sun and
  • Hao Chen
  • + 2 authors

26 September 2022

Background: Primary immune thrombocytopenia (ITP) is an autoimmune disorder. The existence of autoreactive T cells has long been proposed in ITP. Yet the identification of autoreactive T cells has not been achieved, which is an important step to eluc...

  • Article
  • Open Access
15 Citations
7,799 Views
16 Pages

Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach

  • Maria L. Lozano,
  • Cristina Segú-Vergés,
  • Mireia Coma,
  • María T. Álvarez-Roman,
  • José R. González-Porras,
  • Laura Gutiérrez,
  • David Valcárcel and
  • Nora Butta

Eltrombopag is a thrombopoietin receptor (MPL) agonist approved for the treatment of primary immune thrombocytopenia (ITP). Recent evidence shows that some patients may sustain platelet counts following eltrombopag discontinuation. The systemic immun...

  • Article
  • Open Access
4 Citations
2,645 Views
11 Pages

13 February 2023

Systemic immune-inflammation index (SII), which is a good predictive marker for coronary artery disease, can be calculated by using platelet, neutrophil, and lymphocyte counts. The no-reflow occurrence can also be predicted using the SII. The aim of...

  • Perspective
  • Open Access
1 Citations
3,036 Views
9 Pages

Applying a Primary Health Care Approach to Closing the Human Resource for Health Gaps for Immunization

  • Folake Olayinka,
  • Thomas S. O’Connell,
  • Christopher Morgan,
  • Maria Fernanda Monzon,
  • Tokunbo Oshin,
  • Tova Tampe,
  • Alexandra Reed,
  • Giorgio Cometto,
  • Adolphus Trokon Clarke and
  • Muhammad Ahmad Kazi
  • + 1 author

This perspective is focused on the evidence on human resources for health (HRH) solutions for immunization, as a part of a primary health care (PHC) approach.. In the wake of the COVID-19 pandemic and 50 years since the Expanded Program on Immunizati...

  • Review
  • Open Access
23 Citations
9,941 Views
19 Pages

17 December 2021

Membranous nephropathy (MN) is an important cause of nephrotic syndrome and chronic kidney disease (CKD) in adults. The pathogenic significance of B cells in MN is increasingly recognized, especially following the discovery of various autoantibodies...

  • Article
  • Open Access
19 Citations
7,815 Views
9 Pages

Duration of Hepatitis B Vaccine-Induced Protection among Medical Students and Healthcare Workers following Primary Vaccination in Infancy and Rate of Immunity Decline

  • Nanthida Phattraprayoon,
  • Jirapa Kakheaw,
  • Kamonwan Soonklang,
  • Kunsuda Cheirsilpa,
  • Teerapat Ungtrakul,
  • Chirayu Auewarakul and
  • Nithi Mahanonda

10 February 2022

Since the introduction of hepatitis B virus (HBV) vaccines, the numbers of HBV infections and complications have significantly decreased. However, the evidence on whether primary vaccination of infants confers lifelong immunity varies. We aimed to as...

  • Article
  • Open Access
19 Citations
3,423 Views
14 Pages

Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer

  • Katharina Dötzer,
  • Friederike Schlüter,
  • Markus Bo Schoenberg,
  • Alexandr V. Bazhin,
  • Franz Edler von Koch,
  • Andreas Schnelzer,
  • Sabine Anthuber,
  • Dieter Grab,
  • Bastian Czogalla and
  • Alexander Burges
  • + 3 authors

26 August 2019

CD3+ and CD8+ lymphocytes are well known prognostic markers in primary ovarian cancer. In contrast, the predictive value of the immune infiltrate concerning treatment response and the involvement of immune heterogeneity between primary and metastatic...

  • Article
  • Open Access
7 Citations
3,131 Views
11 Pages

1 May 2021

Cytomegalovirus-specific cell-mediated immunity (CMV-CMI) in actively infected healthy immunocompetent hosts has been poorly investigated. Conversely, correlates of maternal protective immunity for the fetus after primary infection in pregnancy conti...

  • Review
  • Open Access
19 Citations
5,250 Views
21 Pages

The innate immune system is critical for natural resistance to all pathogenic microorganisms, including fungi. The innate response plays a vital role in resistance to infections before the antigen-specific immune response and also influences antigen-...

  • Article
  • Open Access
20 Citations
8,830 Views
12 Pages

Newborn Screening for Primary Immune Deficiencies with a TREC/KREC/ACTB Triplex Assay—A Three-Year Pilot Study in Sweden

  • Rolf H. Zetterström,
  • Michela Barbaro,
  • Annika Ohlsson,
  • Stephan Borte,
  • Susanne Jonsson,
  • Jacek Winiarski,
  • Ulrika Von Döbeln and
  • Lennart Hammarström

Background: Screening newborns for severe combined immunodeficiency (SCID) has become essential, since efficient methods to identify infants with these disorders exist and early stem cell transplantation is life-saving. Method: We performed a three-y...

  • Article
  • Open Access
5 Citations
3,445 Views
13 Pages

20 January 2023

Pterygium and primary Sjögren’s Syndrome (pSS) share many similarities in clinical symptoms and ocular pathophysiological changes, but their etiology is unclear. To identify the potential genes and pathways related to immunity, two publish...

  • Article
  • Open Access
7 Citations
3,118 Views
15 Pages

Spatial Distribution of Immune Cells in Primary and Recurrent Glioblastoma: A Small Case Study

  • Delphine Loussouarn,
  • Lisa Oliver,
  • Celine Salaud,
  • Edouard Samarut,
  • Raphaël Bourgade,
  • Christophe Béroud,
  • Emilie Morenton,
  • Dominique Heymann and
  • Francois M. Vallette

20 June 2023

Only a minority of patients with glioblastoma (GBM) respond to immunotherapy, and always only partially. There is a lack of knowledge on immune distribution in GBM and in its tumor microenvironment (TME). To address the question, we used paired prima...

  • Article
  • Open Access
3 Citations
2,308 Views
11 Pages

Immune Persistence against SARS-CoV-2 after Primary and Booster Immunization in Humans: A Large-Scale Prospective Cohort Study

  • Juan Li,
  • Hui Xie,
  • Weixin Chen,
  • Meng Chen,
  • Shuang Bai,
  • Wei Zhao,
  • Tao Zhou,
  • Pei Gao,
  • Lichi Zhang and
  • Quanyi Wang
  • + 3 authors

8 October 2022

Amid the ongoing global COVID-19 pandemic, limited literature exists on immune persistence after primary immunization and the immunogenic features of booster vaccines administered at different time intervals. Therefore, this study aimed to determine...

  • Article
  • Open Access
17 Citations
4,581 Views
16 Pages

Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases

  • Maarit Ahtiainen,
  • Hanna Elomaa,
  • Juha P. Väyrynen,
  • Erkki-Ville Wirta,
  • Teijo Kuopio,
  • Olli Helminen,
  • Toni T. Seppälä,
  • Ilmo Kellokumpu and
  • Jukka-Pekka Mecklin

26 March 2021

Purpose: To evaluate immune cell infiltration, the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) expression and their prognostic value in a series of mismatch proficient (pMMR) CRC with matched liver and lung metastases. Methods: Formalin...

  • Review
  • Open Access
22 Citations
6,741 Views
12 Pages

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?

  • Riccardo Tomasello,
  • Giulio Giordano,
  • Francesco Romano,
  • Federica Vaccarino,
  • Sergio Siragusa,
  • Alessandro Lucchesi and
  • Mariasanta Napolitano

Antiphospholipid syndrome (APS) is frequently associated with thrombocytopenia, in most cases mild and in the absence of major bleedings. In some patients with a confirmed APS diagnosis, secondary immune thrombocytopenia (ITP) may lead to severe thro...

  • Review
  • Open Access
67 Citations
31,175 Views
21 Pages

16 February 2021

Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is associated with frequent bruising and bleeding. Current evidence suggests that...

  • Article
  • Open Access
1,919 Views
28 Pages

9 October 2025

Introduction: Despite global improvements in immunization, major gaps persist. By 2024, an estimated 14.3 million infants, predominantly in low- and middle-income countries (LMICs), remained zero-dose (ZD), never having received even the first DTP va...

  • Review
  • Open Access
16 Citations
13,563 Views
42 Pages

Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults

  • Ida Judyta Malesza,
  • Michał Malesza,
  • Iwona Krela-Kaźmierczak,
  • Aleksandra Zielińska,
  • Eliana B. Souto,
  • Agnieszka Dobrowolska and
  • Piotr Eder

In recent years, the incidence of immune-mediated gastrointestinal disorders, including celiac disease (CeD) and inflammatory bowel disease (IBD), is increasingly growing worldwide. This generates a need to elucidate the conditions that may compromis...

  • Review
  • Open Access
37 Citations
5,998 Views
16 Pages

23 September 2022

Hepatocellular carcinoma (HCC) is the most common liver cancer and a relevant global health problem. Immune checkpoint inhibitors (ICIs) represent the most effective systemic treatment for HCC. However, due to primary resistance, approximately 40% of...

  • Article
  • Open Access
3 Citations
2,206 Views
13 Pages

First Field Test of the Novel Integration Mapping Tool for COVID-19 Vaccination Integration into National Immunization Programs and Primary Healthcare—A Case Study from Côte d’Ivoire

  • Adidja Amani,
  • Ekra Kouadio Daniel,
  • Brou Gbotto,
  • Kossia Yao,
  • Aka Lépri Nicaise,
  • Epa Kouakou,
  • Kouadio Sie Kabran,
  • Gervais Gahongano,
  • Abdoul Gadiry Fadiga and
  • Abdou Aziz Gbaya
  • + 4 authors

12 December 2023

Introduction: With the containment of the COVID-19 pandemic in Côte d’Ivoire, efforts were made to seamlessly integrate COVID-19 vaccination into the national immunization program. A collaborative initiative involving UNICEF, WHO, GAVI, a...

  • Review
  • Open Access
15 Citations
5,180 Views
23 Pages

Congenital cytomegalovirus infection (cCMV) may affect about 1% of all newborns all over the world as a result of either a primary or recurrent human cytomegalovirus (HCMV) infection. While about 90% of infants affected by cCMV are asymptomatic at bi...

  • Review
  • Open Access
12 Citations
6,332 Views
31 Pages

19 January 2023

Primary CNS neoplasms are responsible for considerable mortality and morbidity, and many therapies directed at primary brain tumors have proven unsuccessful despite their success in preclinical studies. Recently, the tumor immune microenvironment has...

  • Article
  • Open Access
2,737 Views
11 Pages

13 March 2025

Background/Objectives: Long-term studies on the immune response following multiple doses of SARS-CoV-2 mRNA vaccines remain limited. Methods: Secondary analyses of data from a cohort of non-immunocompromised subjects who received two doses of BNT162b...

  • Review
  • Open Access
32 Citations
7,292 Views
23 Pages

Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation

  • Chiara Rizzo,
  • Giulia Grasso,
  • Giulia Maria Destro Castaniti,
  • Francesco Ciccia and
  • Giuliana Guggino

Primary Sjogren Syndrome (pSS) is a complex, multifactorial rheumatic disease that mainly targets salivary and lacrimal glands, inducing epithelitis. The cause behind the autoimmunity outbreak in pSS is still elusive; however, it seems related to an...

  • Article
  • Open Access
2 Citations
2,906 Views
14 Pages

Primary and Recall Immune Responses to SARS-CoV-2 in Breakthrough Infection

  • Silvia D’Orso,
  • Marta Pirronello,
  • Alice Verdiani,
  • Angelo Rossini,
  • Gisella Guerrera,
  • Mario Picozza,
  • Manolo Sambucci,
  • Andrea Misiti,
  • Lorenzo De Marco and
  • Antonino Salvia
  • + 4 authors

9 November 2023

Breakthrough infections in SARS-CoV-2 vaccinated individuals are an ideal circumstance for the simultaneous exploration of both the vaccine-induced memory reaction to the spike (S) protein and the primary response to the membrane (M) and nucleocapsid...

  • Review
  • Open Access
3 Citations
2,820 Views
16 Pages

Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer

  • Antonio G. Solimando,
  • Max Bittrich,
  • Endrit Shahini,
  • Federica Albanese,
  • Georg Fritz and
  • Markus Krebs

At the beginning of the COVID-19 pandemic, patients with primary and secondary immune disorders—including patients suffering from cancer—were generally regarded as a high-risk population in terms of COVID-19 disease severity and mortality...

  • Article
  • Open Access
10 Citations
4,959 Views
14 Pages

Dynamic Expression of Interferon Lambda Regulated Genes in Primary Fibroblasts and Immune Organs of the Chicken

  • Mehboob Arslan,
  • Xin Yang,
  • Diwakar Santhakumar,
  • Xingjian Liu,
  • Xiaoyuan Hu,
  • Muhammad Munir,
  • Yinü Li and
  • Zhifang Zhang

14 February 2019

Interferons (IFNs) are pleiotropic cytokines that establish a first line of defense against viral infections in vertebrates. Several types of IFN have been identified; however, limited information is available in poultry, especially using live animal...

  • Brief Report
  • Open Access
11 Citations
4,613 Views
14 Pages

Astrocytes are the most abundant cells in the CNS parenchyma and play an essential role in several brain functions, such as the fine-tuning of synaptic transmission, glutamate uptake and the modulation of immune responses, among others. Much of the k...

  • Article
  • Open Access
978 Views
12 Pages

Transcriptomic Profiling of Paired Primary Tumors and CNS Metastases in Breast Cancer Reveals Immune Modulation Signatures

  • Ana Julia Aguiar de Freitas,
  • Muriele Bertagna Varuzza,
  • Stéphanie Calfa,
  • Rhafaela Lima Causin,
  • Vinicius Duval da Silva,
  • Cristiano de Pádua Souza and
  • Márcia Maria Chiquitelli Marques

Breast cancer is a leading cause of central nervous system (CNS) metastases in women, often associated with poor prognosis and limited therapeutic options. However, molecular differences between primary tumors and CNS metastases remain underexplored....

  • Viewpoint
  • Open Access
6 Citations
5,023 Views
10 Pages

21 April 2023

Primary immune thrombocytopenia (ITP) is an acquired blood disorder that causes a reduction in circulating platelets with the potential for bleeding. The incidence of ITP is slightly higher in adults and affects more women than men until 60 years, wh...

  • Article
  • Open Access
4 Citations
5,015 Views
9 Pages

Immunogenicity and Safety of a Booster Dose of Live Attenuated Varicella Vaccine, and Immune Persistence of a Primary Dose for Children Aged 2 to 6 Years

  • Yukai Zhang,
  • Lei Wang,
  • Yanxia Wang,
  • Wei Zhang,
  • Ningning Jia,
  • Zhiqiang Xie,
  • Lili Huang,
  • Wangyang You,
  • Weifeng Lu and
  • Erwei Li
  • + 4 authors

22 April 2022

Aim: To evaluate the immunogenicity and safety of a booster dose of live attenuated varicella vaccine (VarV) manufactured by Sinovac (Dalian) Vaccine Technology Co. Ltd., and the immune persistence of a primary dose in 2- to 6-year-old children. Meth...

  • Article
  • Open Access
19 Citations
3,458 Views
10 Pages

25 July 2022

The tumor microenvironment plays a vital role in tumor progression and treatment response. However, the association between immune cell concentrations in primary tumor and blood indexes remains unknown. Thus, we enrolled patients with gastric cancer...

  • Communication
  • Open Access
14 Citations
3,843 Views
15 Pages

Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with ALK Rearrangement-Positive Large Cell Neuroendocrine Carcinoma

  • Takahiro Tashiro,
  • Kosuke Imamura,
  • Yusuke Tomita,
  • Daisuke Tamanoi,
  • Akira Takaki,
  • Kazuaki Sugahara,
  • Ryo Sato,
  • Koichi Saruwatari,
  • Shinya Sakata and
  • Megumi Inaba
  • + 3 authors

19 December 2020

Evolution of tumor-immune microenviroments (TIMEs) occurs during tumor growth and dissemination. Understanding inter-site tumor-immune heterogeneity is essential to harness the immune system for cancer therapy. While the development of immunotherapy...

  • Article
  • Open Access
1 Citations
2,102 Views
17 Pages

Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma

  • Guannan Jiang,
  • Zong-Qing Zheng,
  • Jie Zhang,
  • Zhichao Tian,
  • Xiang Li,
  • Zhengquan Yu,
  • Zhong Wang,
  • Wanchun You and
  • Gang Chen

1 August 2023

Glioblastoma (GBM) is a highly malignant and aggressive tumor with poor prognosis. Therefore, the discovery of new prognostic molecular markers is of great significance for clinical prognosis. The CXC chemokine receptor (CXCR) members play a key regu...

of 96